pubs.rsc.org
Sequence-defined phosphoestamers for selective inhibition of the KRASG12D/RAF1 interaction
RAS proteins are the most frequently mutated in cancer, yet they have proved extremely difficult to target in drug discovery, largely because interfering with the interaction of RAS with its downstrea...